Tubitere Novo

Yes, Tubitere Novo 120mg Injection may cause weight gain. It may occur due to fluid retention which may initially make your feet swell and then gradually it will spread to the whole body. Call your doctor immediately if you notice swelling of feet.

You should continue to take Tubitere Novo 120mg Injection as long as your doctor advises you. The duration of treatment varies with the type of cancer you have and other factors like your response to treatment. You should usually receive your infusion once every 3 weeks.

Tubitere Novo 120mg Injection injection contains alcohol because of which you may experience confusion, stumbling, becoming very sleepy, or feeling like you are drunk. This may impair your ability to drive or use machinery right after receiving it. Hence, you should avoid alcohol during Tubitere Novo 120mg Injection therapy, as it may affect you adversely.

Tubitere Novo 120mg Injection is commonly used for breast cancer, certain types of lung cancer, prostate, stomach, and head and neck cancers. It works by restricting cells from growing and multiplying.

No, Tubitere Novo 120mg Injection injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given over 1 hour once every 3 weeks.

Your doctor will ask you to get blood tests every time you have a scheduled dose of Tubitere Novo 120mg Injection. You may be asked to have blood tests, such as hemogram and liver function tests, to ensure that you have enough blood cells and that your liver is functioning well enough to receive Tubitere Novo 120mg Injection. In case of white blood cells disturbances, you may experience associated fever or infections.

Hair loss is a common side effect of Tubitere Novo 120mg Injection. Normal hair growth may resume after stopping Tubitere Novo 120mg Injection. However, in some cases there is permanent hair loss. Consult your doctor if you have any concerns regarding hair loss.

Tubitere Novo 120mg Injection may cause fluid retention (swelling in the hands, feet, ankles and legs) as well as severe hypersensitivity reactions. To control such possibilities from occurring all patients are given corticosteroids (dexamethasone) for 3 days starting 1 day prior to Tubitere Novo 120mg Injection administration. In case of prostate cancer (metastatic castration-resistant), the recommended regimen is oral dexamethasone given at 12 hours, 3 hours, and 1 hour before the Tubitere Novo 120mg Injection infusion.

Tubitere Novo 120mg Injection belongs to the group of anti-cancer medicines called taxoids. It works by stopping the growth and spread of cancer cells.